Koers Dizal (Jiangsu) Pharmaceutical Co., Ltd.
Aandelen
688192
CNE1000055W8
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
42,18 CNY | +0,86% | +12,78% | -11,85% |
Omzet 2023 | 91,29 mln. 12,6 mln. 11,75 mln. | Omzet 2024 * | 490 mln. 67,61 mln. 63,05 mln. | Marktkapitalisatie | 17,53 mld. 2,42 mld. 2,26 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2023 | -1,12 mld. -155 mln. -145 mln. | Nettowinst (verlies) 2024 * | -649 mln. -89,55 mln. -83,51 mln. | EV/omzet 2023 | 214 x |
Nettoliquiditeiten 2023 * | - 0 0 | Nettoliquiditeiten 2024 * | - 0 0 | EV/omzet 2024 * | 35,8 x |
K/w-verhouding 2023 |
-17,4
x | K/w-verhouding 2024 * |
-27
x | Werknemers | 424 |
Dividendrendement 2023 * |
-
| Dividendrendement 2024 * |
-
| Vrij verhandelbaar | 18,48% |
1 dag | +0,86% | ||
1 week | +12,78% | ||
Lopende maand | -6,25% | ||
1 maand | -2,86% | ||
3 maanden | +12,81% | ||
6 maanden | +20,17% | ||
Lopend jaar | -11,85% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Xiao Lin Zhang
CEO | Chief Executive Officer | 60 | 27-10-17 |
Wei Wen Dong
CHM | Chairman | 38 | 01-06-18 |
Hong Bin Lu
DFI | Director of Finance/CFO | 46 | 01-07-20 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Simon Lü
BRD | Director/Board Member | 56 | 01-10-17 |
Xue Gong Wang
BRD | Director/Board Member | 52 | 07-09-20 |
Guan Shan Zhu
BRD | Director/Board Member | 60 | 08-09-20 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
24-04-24 | 42,18 | +0,86% | 2 589 122 |
23-04-24 | 41,82 | +10,99% | 3 851 922 |
22-04-24 | 37,68 | +6,44% | 2 325 619 |
19-04-24 | 35,4 | -4,71% | 2 408 522 |
18-04-24 | 37,15 | -0,67% | 1 599 289 |
slotkoers Shanghai S.E., 24 april 2024
Meer koersenHerzieningen van WPA
Winst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-11,85% | 2,42 mld. | |
-1,51% | 104 mld. | |
+3,22% | 97,42 mld. | |
+1,46% | 22,2 mld. | |
-16,53% | 21,23 mld. | |
-9,10% | 18,33 mld. | |
-42,33% | 16,35 mld. | |
-20,09% | 15,06 mld. | |
+5,47% | 13,98 mld. | |
+28,85% | 11,66 mld. |